RE: Sub 9p coming!6 Oct 2023 10:25
I thought we’d been told , perhaps via an email from the company to an individual share holder that FDA was off the table..? Cd be imagining that but I think it’s highly unlikely GDr will suddenly find the £2m required to submit an application. If we’d qualified for De Novo or D510 routes, which are much quicker and cheaper, we would definitely have been told. As far as I’m concerned the US market is only a long term option, possibly a couple of years after AIHL and CYP1C19 are established in the UK market and generating revenue that can guarantee paying for the FDA applications.